在常见的临床实践中使用的罗斯瓦斯塔丁的安全性:营销后分析
Alawi A Alsheikh-Ali1, Marietta S Ambrose, Jeffrey T Kuvin
1Molecular Cardiology Research Institute, Department of Medicine, Tufts-New England Medical Center, 750 Washington St, Boston, MA 02111, USA.
Circulation
|May 25, 2005
概括
罗苏瓦斯塔丁是一种常见的他类药物,与其他他类药物相比,其严重不良事件比率更高,比如狂肌痛和脏问题. 这些风险在治疗的早期观察到,即使在中等剂量.
科学领域:
- 药物监督 药物监督 药物监督
- 心血管疾病管理管理
- 药物安全评估 药物安全评估
背景情况:
- 类药物是治疗失脂症和预防心血管疾病的主要治疗方法.
- 基于初步研究和报告,人们对一种较新的他类药物 - - 罗斯瓦斯塔丁 (rosuvastatin) 的安全存在担忧.
研究的目的:
- 评估与其他他类药物相比,罗斯瓦斯塔丁的安全性.
- 评估在第一年营销期间与罗斯瓦斯塔丁相关的不良事件报告.
主要方法:
- 美国食品和药物管理局对罗斯瓦斯塔丁的不良事件报告 (AER) 的审查.
- 使用IMS健康数据计算每百万处方的AER率.
- 与阿托瓦斯塔丁,西姆瓦斯塔丁和普拉瓦斯塔丁的罗苏瓦斯塔丁AER率进行比较.
主要成果:
- 罗斯瓦斯塔丁的AER比率显著更高,用于狂犬病溶解,蛋白尿,脏病或功能衰竭.
- 这些严重事件通常发生在治疗的早期和适度的罗斯瓦斯塔丁剂量.
- 在二次分析中也注意到罗斯瓦斯塔丁的AER增加,包括肝脏和肌肉毒性.
结论:
- 这些发现支持了人们在一般临床实践中对罗斯瓦斯塔丁的相对安全性的担忧.
- 与其他广泛使用的他类药物相比,罗斯瓦斯塔丁可能会带来更高的严重不良事件风险.
相关概念视频
Clinical Trials
11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.2K
Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
557
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
557
Bioavailability Study Design: Healthy Subjects Versus Patients
213
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
213
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
338
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
338


